BIOTECHNOLOGY VALUE FUND L P → XOMA Corp XOMAP

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.00

625 shares short · +2876.2% vs prior

Other 13D/G Filings on XOMA Corp

Filed	Form	Filer	Stake	Shares
2025-01-28	SCHEDULE	BIOTECHNOLOGY VALUE FUND L P	25.30%	2,983,026	view →

Other Filings by BIOTECHNOLOGY VALUE FUND L P

Filed	Form	Issuer	Stake	Shares
2026-04-02	SCHEDULE 13D/A	MoonLake Immunotherapeutics MLTX	22.30%	8,302,735	view →
2025-01-28	SCHEDULE	XOMA Royalty Corp XOMAP	25.30%	2,983,026	view →
2024-01-09	SC	Kymera Therapeutics, Inc. KYMR	—	—	view →
2018-02-12	SC	CTI BIOPHARMA CORP	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →